bioMérieux: Strong start of the year driven by the US

BUY, Fair Value EUR110 (+19%)
News published on April Thursday 23, 2015
Share on

Biomérieux released Q1 results with sales up 21% on a reported basis, standing at EUR448m (vs. EUR371m in 2014). A strong currency effect of 10.1% in Q1, mainly from the US, should not overshadow robust organic growth of 8.7% over the quarter which came in higher than the confirmed 4.5-6.5% organic growth range guidance for the year. BioFire sales are up 93% at EUR37m which could help the company to surpass its annual guidance if the same growth pace is sustained throughout 2015.

For more information please contact 

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities